Singular Health Secures US$500,000 as PNS Expands Use of 3DICOM MD

Singular Health Group Ltd ( (AU:SHG) ) has provided an update.

Singular Health Group has received US$500,000 from U.S.-based Provider Network Solutions under a binding enterprise agreement linked to the deployment of its 3DICOM MD medical imaging licences. The payment follows the rollout of an additional 500 licences, completing contractual obligations and significantly broadening the platform’s reach across PNS’s network of around 4.2 million covered lives.

The 3DICOM MD platform is seeing rising utilisation within PNS’s clinical workflows and is reported to be generating meaningful cost efficiencies by cutting duplicate imaging and improving access to patient data. On the back of these positive results, Singular Health and PNS have begun talks on renewing and potentially expanding their licensing arrangement, signalling growing commercial traction and the prospect of wider adoption among U.S. healthcare plans.

More about Singular Health Group Ltd

Singular Health Group Ltd is an ASX-listed medical software technology company focused on unlocking the full value of medical imaging records through integrated, interoperable platforms. Its flagship 3Dicom software, including 3DICOM MD, enables patients and clinicians to better visualise and communicate medical imaging data, with 3DICOM MD cleared for diagnostic use in the U.S. market.

Average Trading Volume: 439,780

Technical Sentiment Signal: Sell

Current Market Cap: A$77.41M

For a thorough assessment of SHG stock, go to TipRanks’ Stock Analysis page.